Extent of Protocol deviation accepted by the Agency [Regulatives / Guidelines]

posted by bharathi – India, 2014-09-16 14:19 (3508 d 14:05 ago) – Posting: # 13519
Views: 4,113

Dear All,

I am performing fasting and fed Bioequivalence studies for an X product. Design of the study is parallel as recommended by the Agency.

Fasting and Fed studies are divided each into 2 groups.

Fed study was completed with 2 groups (Each group with 40 subjects, 20 each of test and reference.

Analysis was done and proved to be bioequivalent.

In fasting study, only group 1 is completed and there's no time for the group 2 to be completed. So can I analyze and if it is bioequivalent, will Agency accepts by proposal (deviation from the protocol that group 2 was not performed?)

Please can you clarify the same

Regards,
Bharathi

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
97 visitors (0 registered, 97 guests [including 7 identified bots]).
Forum time: 04:25 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5